Vacuum-sealing as a treatment option for severe anthracycline extravasation in a breast cancer patient

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Background: Compared to peripheral venous access, central lines greatly reduce the incidence of cytotoxic extravasation. Although implantable vascular systems are widely used in oncology, extended extravasation lesions in cancer patients remain complicated. Patient and Method: A 67-year-old female breast cancer patient suffered from an extended lesion of a catheter port extravasation. A vacuum-sealing therapy was initiated to accelerate the healing of the anthracycline-induced wound. Result: The vacuum-sealing technique allowed a fast and successful treatment of the extravasation lesion. Conclusion: Due to the myelosuppressive chemotherapy regimen, the risk of wound infections and prolonged healing processes is increased in cancer patients. Moreover, disruption or cancellation of anticancer therapies worsens the patients' prognosis. To attenuate these complications the vacuum-sealing technique should be considered in wound management concepts. Copyright © 2008 S. Karger AG.

Cite

CITATION STYLE

APA

Rhiem, K., Nemat, A. T., Schmutzler, R. K., Krick, M., Mallmann, P., & Warm, M. (2008). Vacuum-sealing as a treatment option for severe anthracycline extravasation in a breast cancer patient. Breast Care, 3(5), 347–348. https://doi.org/10.1159/000154141

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free